1. Home
  2. MGIC vs JSPRW Comparison

MGIC vs JSPRW Comparison

Compare MGIC & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGIC
  • JSPRW
  • Stock Information
  • Founded
  • MGIC 1983
  • JSPRW N/A
  • Country
  • MGIC Israel
  • JSPRW United States
  • Employees
  • MGIC N/A
  • JSPRW 45
  • Industry
  • MGIC Computer Software: Prepackaged Software
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGIC Technology
  • JSPRW Health Care
  • Exchange
  • MGIC Nasdaq
  • JSPRW Nasdaq
  • Market Cap
  • MGIC N/A
  • JSPRW N/A
  • IPO Year
  • MGIC 1991
  • JSPRW 2020
  • Fundamental
  • Price
  • MGIC $11.89
  • JSPRW $0.22
  • Analyst Decision
  • MGIC Buy
  • JSPRW
  • Analyst Count
  • MGIC 1
  • JSPRW 0
  • Target Price
  • MGIC $15.00
  • JSPRW N/A
  • AVG Volume (30 Days)
  • MGIC 42.2K
  • JSPRW N/A
  • Earning Date
  • MGIC 11-18-2024
  • JSPRW N/A
  • Dividend Yield
  • MGIC 1.71%
  • JSPRW N/A
  • EPS Growth
  • MGIC N/A
  • JSPRW N/A
  • EPS
  • MGIC 0.70
  • JSPRW N/A
  • Revenue
  • MGIC $535,482,999.00
  • JSPRW N/A
  • Revenue This Year
  • MGIC $4.29
  • JSPRW N/A
  • Revenue Next Year
  • MGIC $3.39
  • JSPRW N/A
  • P/E Ratio
  • MGIC $17.20
  • JSPRW N/A
  • Revenue Growth
  • MGIC N/A
  • JSPRW N/A
  • 52 Week Low
  • MGIC $9.38
  • JSPRW N/A
  • 52 Week High
  • MGIC $13.40
  • JSPRW N/A
  • Technical
  • Relative Strength Index (RSI)
  • MGIC 49.67
  • JSPRW N/A
  • Support Level
  • MGIC $11.51
  • JSPRW N/A
  • Resistance Level
  • MGIC $12.24
  • JSPRW N/A
  • Average True Range (ATR)
  • MGIC 0.30
  • JSPRW 0.00
  • MACD
  • MGIC -0.07
  • JSPRW 0.00
  • Stochastic Oscillator
  • MGIC 33.33
  • JSPRW 0.00

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: